FDA RegulationConflicting Demands
Pharma, medical device, food, and cosmetics companies face enormous challenges from global competitors and regulatory frameworks seeking to balance public safety and innovation. At the same time, technology and patient demands have led to enormous opportunity in areas, such as digital health and clinical trial innovation. We understand these complexities and help companies navigate the regulatory landscape throughout the lifecycle of their products — from development to marketing — all while maintaining a constant focus on business objectives.
Our team develops effective strategies for market entry and for meeting FDA requirements, and also provides corporate due diligence in acquisitions, sales, and mergers of companies in both traditionally regulated sectors, as well as emerging treatment options. Our multidisciplinary team uses an integrated approach when providing effective and efficient legal services to FDA-regulated companies, including handling client matters before the Federal Trade Commission (FTC), Consumer Product Safety Commission (CSPC), and the National Advertising Division of the Better Business Bureau (NAD).
Kilpatrick Townsend’s FDA Regulatory Practice Group includes professionals who have a specialized cross-industry understanding of areas, including health care, life sciences, and technology — all of which are relevant to the lifecycle of an FDA-regulated product.
Stephen R. Berlin